Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in BMY — Bristol Myers Squibb Co

CIK 886982 NEW YORK, NY
Back to BMY Full portfolio

Position in BMY

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$852,406,514
-$137,013,662 QoQ
Shares Held
14,054,518
-23.4% QoQ
Ownership
0.688%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 94.85017558054997.ToString("F0")% Shared 0.ToString("F0")% None 5.14982441945003.ToString("F0")%

Common Shares in BMY Over Time

Shares Held

Position Value (USD)

Derivatives in BMY

reported options exposure · as of Mar 31, 2026
CallValue
$27,771,635
CallShares
457,900
PutValue
$3,178,060
PutShares
52,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $25,307,344,615 across 17 Drug Manufacturers - General names. BMY ranks #10 (3.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 6,340,865 $5,832,137,397
2 JNJ
Johnson & Johnson
 18,057,047 $4,413,864,566
3 ABBV
AbbVie Inc.
 15,145,279 $3,293,946,727
4 MRK
Merck & Co., Inc.
 20,133,379 $2,421,844,158
5 AZN
Astrazeneca PLC
 10,605,842 $2,091,684,157
6 GILD
Gilead Sciences, Inc.
 11,065,214 $1,542,158,873
7 AMGN
Amgen Inc
 4,219,989 $1,484,803,127
8 PFE
Pfizer Inc
 47,105,556 $1,322,724,010

All Filings in BMY

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $852,406,514 14,054,518
2026-03-31 $3,178,060 52,400
2026-03-31 $27,771,635 457,900
2025-12-31 $989,420,176 18,342,977
2025-12-31 $18,528,390 343,500
2025-12-31 $11,187,156 207,400
2025-09-30 $15,491,850 343,500
2025-09-30 $793,082,687 17,584,982
2025-09-30 $43,728,960 969,600
2025-06-30 $22,709,874 490,600
2025-06-30 $7,193,466 155,400
2025-06-30 $569,877,484 12,311,028
2025-03-31 $807,825,905 13,245,219
2025-03-31 $25,585,305 419,500
2025-03-31 $23,578,734 386,600
2024-12-31 $695,878,604 12,303,370
2024-12-31 $49,433,440 874,000
2024-12-31 $28,545,832 504,700
2024-09-30 $42,152,578 814,700
2024-09-30 $657,631,021 12,710,302
2024-09-30 $18,885,100 365,000
2024-06-30 $653,712,389 15,740,727
2024-06-30 $15,158,450 365,000
2024-06-30 $122,729,456 2,955,200
2024-03-31 $866,137,641 15,971,559
2024-03-31 $178,302,817 3,287,900
2024-03-31 $24,739,726 456,200
2023-12-31 $19,174,547 373,700
2023-12-31 $839,407,789 16,359,536
2023-12-31 $152,247,032 2,967,200
2023-09-30 $17,272,704 297,600
2023-09-30 $40,668,628 700,700
2023-09-30 $1,006,650,284 17,344,078
2023-06-30 $10,385,480 162,400
2023-06-30 $13,704,485 214,300
2023-06-30 $1,055,426,959 16,503,940
2023-03-31 $7,339,929 105,900
2023-03-31 $3,742,740 54,000
2023-03-31 $1,190,317,323 17,173,818
2022-12-31 $19,476,865 270,700
2022-12-31 $1,129,866,318 15,703,493
2022-12-31 $10,562,260 146,800
2022-09-30 $13,492,882 189,800
2022-09-30 $6,163,503 86,700
2022-09-30 $1,104,839,544 15,541,420
2022-06-30 $1,105,496,931 14,357,103
2022-06-30 $17,717,700 230,100
2022-06-30 $22,676,500 294,500
2022-03-31 $9,559,627 130,900
2022-03-31 $1,176,434,863 16,108,926

Report a Problem

Category
Description
Email (optional, for follow-up)